Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $7.7 Million - $10.3 Million
13,000 Added 96.3%
26,500 $20.6 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $7.09 Million - $8.36 Million
13,500 New
13,500 $7.87 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alphadyne Asset Management LP Portfolio

Follow Alphadyne Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphadyne Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Alphadyne Asset Management LP with notifications on news.